Image: Ted Eytan · CC BY-SA 4.0 (attribution, share-alike; not adapted) · Flickr · https://creativecommons.org/licenses/by-sa/2.0/
The first over-the-counter glucose biosensor in the US, sold by monthly subscription without a prescription.
What it changes
Puts continuous glucose data in the hands of people without diabetes who do not need a clinician’s order, turning a clinical device into a consumer purchase.
Availability
Generally available (us)
Access and cost
Get Dexcom Stelo — $89 a month on subscription, down from $99, and HSA/FSA eligible; no prescription is required.
Evidence it works
- Advertises Stelo at $89 for a monthly subscription, marked down from $99, and flags HSA/FSA eligibility. — source
- Announced Stelo as the first over-the-counter glucose biosensor available in the United States. — source
Practical limits
- Each sensor is rated for 15 days, and Dexcom says about 20% may not last the full period.
- Coaching tips in the app are not medical advice, and the product is not intended for insulin dosing.
Dexcom · Hardware · Last verified 2026-09-17. Claims are re-checked on a 30-day clock; the date above is when this line was last confirmed.
About the Author
